跳至主要内容
临床试验/NCT03596996
NCT03596996已完成不适用

Optimizing Iron Status While Minimizing Morbidity in HIV-infected Ugandan Children

University of Minnesota1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2018年4月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
1
主要终点
Anemia

研究概览

简要总结

Randomized, placebo-controlled trial of the effect of 84 days of daily iron supplementation on iron status, gut microbiome profile, infectious disease frequency, and HIV disease severity in moderately anemic [hemoglobin 9 - <11 g/dL (6-59 mo); hemoglobin 9 - < 11.5 g/dL (5 -12 years)], HIV-infected Ugandan children between the ages of 6 mos and 12 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Months 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of HIV (based JCRC clinic records);
  • On Highly Active Antiretroviral Treatment (HAART) for ≥ 6 months
  • Age 6 months - 12 years at the time of screening
  • Hemoglobin 9 - <11 g/dL (6-59 mo); hemoglobin 9 - < 11.5 g/dL (5 -12 years)by CBC at time of screening

排除标准

  • Acute illness or current opportunistic infection
  • Temperature >= 38.0°C at the time of screening
  • Known sickle cell disease
  • Acute malnutrition (bilateral pitting edema or extreme wasting)
  • Any chronic illness requiring regular medical attention
  • Residence > 50 km from JCRC hospital
  • Non-English or Luganda speaking
  • Currently taking iron supplements

结局指标

主要结局

Anemia

时间窗: 3 months

Prevalence of anemia

Iron status

时间窗: 3 months

Iron status measured using ferritin, sTfR, CRP and hepcidin concentration in plasma

Hemoglobin

时间窗: 3 months

Measurement of hemoglobin

次要结局

  • Dietary iron absorption(2 weeks)
  • Sick Child Visits(3 months)
  • HIV virologic control(3 month)
  • HIV related immunosuppression(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验